(Q72149455)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070018%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

title

Clinical studies of irinotecan alone and in combination with cisplatin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070018%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference

1 reference

M Fukuoka

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070018%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

N Masuda

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070018%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070018%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

24 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070018%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

volume

34 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070018%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

page(s)

S105-11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070018%20AND%20SRC:MED&resulttype=core&format=json

Enhanced antitumor efficacy of a combination of CPT-11, a new derivative of camptothecin, and cisplatin against human lung tumor xenografts.

24 October 2019

cites work

1 reference

12 December 2020

Lethal activity of camptothecin sodium on human lymphoma cells.

1 reference

12 December 2020

CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer

1 reference

12 December 2020

Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I

1 reference

12 December 2020

New natural products in cancer chemotherapy

1 reference

12 December 2020

CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer

1 reference

12 December 2020

Phase I Study of Weekly Intravenous Infusions of CPT-11, a New Derivative of Camptothecin, in the Treatment of Advanced Non-Small-Cell Lung Cancer

1 reference

12 December 2020

Plasma camptothecin (NSC-100880) levels during a 5-day course of treatment: relation to dose and toxicity.

1 reference

12 December 2020

Phase I clinical study of CPT-11. Research group of CPT-11

1 reference

12 December 2020

Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880).

1 reference

12 December 2020

Phase I and pharmacologic study of irinotecan in combination with cisplatin for advanced lung cancer

1 reference

12 December 2020

Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothec in, a novel water-soluble derivative of camptothecin, against murine tumors

1 reference

12 December 2020

An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma.

1 reference

12 December 2020

Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.

1 reference

12 December 2020

CPT-11 Converting Enzyme from Rat Serum: Purification and Some Properties

1 reference

12 December 2020

Review of the current clinical status of platinum coordination complexes in cancer chemotherapy

1 reference

12 December 2020

[Effect of administration schedules on the antitumor activity of CPT-11, a camptothecin derivative]

1 reference

12 December 2020

Action of camptothecin on mammalian cells in culture

1 reference

12 December 2020

Action of (S)-10-hydroxycamptothecin on P388 leukemia and distribution of the drug in mice

1 reference

12 December 2020

A new international staging system for lung cancer

1 reference

12 December 2020

Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo

1 reference

12 December 2020

Antitumor activity of a new camptothecin derivative, SN-22, against various murine tumors.

1 reference

12 December 2020

Mechanism of action of cis-dichlorodiammineplatinum(II)

1 reference

12 December 2020

Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11

1 reference

12 December 2020

Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer

1 reference

12 December 2020

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer

1 reference

12 December 2020

[Distribution and excretion of 10-hydroxycamptothecin and its influence on immune response (author's transl)]

1 reference

12 December 2020

Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.

1 reference

12 December 2020

Studies on the antitumor activity, mechanism of action, and cell cycle effects of camptothecin

1 reference

12 December 2020

Treatment of malignant melanoma with camptothecin (NSC-100880)

1 reference

12 December 2020

Action of 7-ethylcamptothecin on tumor cells and its disposition in mice

1 reference

12 December 2020

Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.

1 reference

12 December 2020

Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00684873

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8070018%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference